NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program CULVER CITY, Calif.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ:…